Ethopropazine (hydrochloride)
(Synonyms: 盐酸乙丙嗪,Isothazine hydrochloride; Lysivane hydrochloride; Parsidol hydrochloride) 目录号 : GC47314A BChE inhibitor
Cas No.:1094-08-2
Sample solution is provided at 25 µL, 10mM.
Ethopropazine is a butyrylcholinesterase (BChE) inhibitor (IC50 = 15.14 µM in human erythrocyte lysates).1 It is selective for BChE over acetylcholinesterase (AChE) at 500 µM. Ethopropazine also binds to rat forebrain and hindbrain membrane preparations (Kis = 3.1 and 7.2 nM, respectively), which are endogenously enriched in M1 and M2 muscarinic acetylcholine receptors, respectively.2 Ethopropazine (0.232 mg/kg) decreases the intensity and increases the latency of haloperidol-induced catalepsy, a model of extrapyramidal syndrome, in rats when used in combination with the adenosine A2A receptor antagonist ZM 241395 .3 It reduces thermal hyperalgesia in a rat model of neuropathic pain induced by sciatic nerve ligation when administered at doses of 20 and 30 mg/kg.4 Formulations containing ethopropazine were previously used in the treatment of Parkinson's disease.
1.Ucar, G., Gokhan, N., Yesilada, A., et al.1-N-Substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: a novel cholinesterase and selective monoamine oxidase B inhibitors for the treatment of Parkinson's and Alzheimer's diseasesNeurosci. Lett.382(3)327-331(2005) 2.Burke, R.E.The relative selectivity of anticholinergic drugs for the M1 and M2 muscarinic receptor subtypesMov. Disord.1(2)135-144(1986) 3.GonzÁlez-Lugo, O.E., Ceballos-Huerta, F., JimÉenez-Capdeville, M.E., et al.Synergism of theophylline and anticholinergics to inhibit haloperidol-induced catalepsy: A potential treatment for extrapyramidal syndromesProg. Neuropsychopharmacol. Biol. Psychiatry34(8)1465-1471(2010) 4.Jevtovic-Todorovic, V., Meyenburg, A.P., Olney, J.W., et al.Anti-parkinsonian agents procyclidine and ethopropazine alleviate thermal hyperalgesia in neuropathic ratsNeuropharmacology44(6)739-748(2003)
Cas No. | 1094-08-2 | SDF | |
别名 | 盐酸乙丙嗪,Isothazine hydrochloride; Lysivane hydrochloride; Parsidol hydrochloride | ||
Canonical SMILES | CC(N(CC)CC)CN1C2=C(C=CC=C2)SC3=CC=CC=C31.Cl | ||
分子式 | C19H24N2S.HCl | 分子量 | 348.9 |
溶解度 | DMF: 10mg/mL,DMF:PBS (pH 7.2) (1:5): 0.16mg/mL,DMSO: 5mg/mL,Ethanol: 5mg/mL | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.8662 mL | 14.3308 mL | 28.6615 mL |
5 mM | 0.5732 mL | 2.8662 mL | 5.7323 mL |
10 mM | 0.2866 mL | 1.4331 mL | 2.8662 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet